Roundup cancer claims are often described as a class action. That description is wrong. The lawsuits over glyphosate and non-Hodgkin lymphoma are mass torts. The difference is not a technical label. It decides who controls the case, who gets paid, and how long it takes. A class action puts one person or a small group in charge of everyone’s claims. A mass tort keeps each injured person’s claim separate. The cases may travel together for a while, but they do not become one giant lawsuit.

A true class action works when thousands of people suffer the same small harm from the same conduct. Maybe a company overcharges fees or sends illegal robocalls. The facts are nearly identical. One trial can answer the main questions for everyone. If the class wins, the money is divided by a formula. That is efficient. It is also not how Roundup cancer cases work.

Cancer is not identical from person to person. One plaintiff may have used Roundup on a small lawn for two years. Another may have sprayed it daily for decades as a landscaper. One may have a type of lymphoma with a long delay between exposure and diagnosis. Another may have other risk factors, such as age, immune disease, or prior chemical exposure. The law asks whether glyphosate caused this person’s cancer, not whether it could cause cancer in general. That question requires individual medical proof.

The federal Roundup cases were gathered into a multidistrict litigation, often called MDL 2741. An MDL is a procedural tool. It centralizes pretrial work in one court so that discovery, depositions, and expert challenges do not happen hundreds of times. The MDL judge manages the process. But the MDL does not turn the cases into a class action. Each plaintiff keeps their own claim. If a case does not settle, it can be sent back to its original court for trial.

Bellwether trials are a key part of this process. A small number of cases are chosen to go to trial first. They are not chosen because they are perfect. They are chosen to test how juries react to the evidence. Some Roundup bellwether verdicts went to plaintiffs. Some went to Monsanto, now owned by Bayer. Appeals followed. Those mixed results show why one class-wide trial would be risky for both sides. A single loss or win would not fairly resolve thousands of different claims.

Damages also differ. In a class action, everyone might get the same refund or a set payment. In a mass tort, one plaintiff may need years of cancer treatment. Another may have lost wages and health insurance. Another may have died, leaving a family with funeral bills and grief. The law allows different amounts for medical costs, pain, suffering, lost income, and loss of companionship. No formula can capture all of that in one class-wide award.

Bayer has settled many Roundup claims without admitting fault. Those settlements are usually not one-size-fits-all. They may create tiers based on diagnosis, exposure history, age, and other factors. Lawyers negotiate for individual clients or groups of clients. A person who never opts in is not bound by another person’s deal. That is mass tort thinking. It gives each claimant a chance to evaluate their own proof and decide whether to settle or continue.

The science remains contested. The World Health Organization’s cancer agency classified glyphosate as probably carcinogenic to humans. The U.S. Environmental Protection Agency has said it is not likely to be carcinogenic. Juries hear both sides. Courts also decide which expert witnesses may testify. If appeals restrict causation testimony, many claims become harder. If the testimony survives, settlement pressure grows.

For anyone following these claims, the practical lesson is simple. Roundup litigation is not one case. It is a collection of individual fights grouped together for efficiency. That structure protects differences among plaintiffs, but it also means outcomes vary. A strong claim depends on exposure records, medical records, expert support, and state law. A weak claim may settle for little or nothing. The label matters because it tells you what the fight really is. It also explains why no single court date will end every Roundup case at once. Some claims will settle quietly while others keep moving through appeals.